Summary

Fortis Healthcare Ltd. reported strong financial performance for both Q4 FY26 and the full fiscal year FY26. Consolidated revenues for Q4 FY26 grew 17.8% year-over-year to ₹2,365 crore, while full-year FY26 revenues increased by 17.3% to ₹9,128 crore. The company saw a significant improvement in profitability, with Q4 FY26 Profit After Tax soaring by 44.2% to ₹271 crore and full-year PAT rising 31.5% to ₹1,064 crore. Operating EBITDA margins expanded to 22.5% in Q4 FY26 and 22.8% for the full year, up from 21.7% and 20.4% respectively. The Board has also recommended a dividend of ₹1 per share.

Key Highlights

1. 1

   Consolidated revenues for Q4 FY26 reached ₹2,365 crore, marking a significant 17.8% increase year-over-year.

2. 2

   For the full fiscal year FY26, consolidated revenues stood at ₹9,128 crore, reflecting a robust 17.3% growth compared to FY25.

3. 3

   Operating EBITDA for Q4 FY26 increased by 22.2% to ₹531 crore, with margins improving to 22.5% from 21.7% in Q4 FY25.

4. 4

   Full-year FY26 Operating EBITDA grew by 31.3% to ₹2,085 crore, with margins expanding to 22.8% from 20.4% in FY25.

5. 5

   Profit After Tax for Q4 FY26 surged by 44.2% to ₹271 crore, while FY26 PAT rose by 31.5% to ₹1,064 crore.

6. 6

   The Board of Directors recommended a dividend of ₹1 per share, representing 10% of the face value.

7. 7

   Net debt as of March 31, 2026, was ₹2,334 crore, with a Net Debt to EBITDA ratio of 1.09x.